Peter Johnston, a director at $TROX, bought 20,000 shares of the company on 08-12-2025 for an estimated $64,200. This trade was reported by Quiver Quantitative using data from a recent SEC filing. This increased their holdings of this class of stock by approximately 11.7%. Following this trade, they now own 191,513 shares of this class of $TROX stock.
$TROX Insider Trading Activity
$TROX insiders have traded $TROX stock on the open market 11 times in the past 6 months. Of those trades, 11 have been purchases and 0 have been sales.
Here’s a breakdown of recent trading of $TROX stock by insiders over the last 6 months:
- JOHN D ROMANO (CEO and Director) purchased 100,000 shares for an estimated $308,930
- STEPHEN J JONES has made 4 purchases buying 51,000 shares for an estimated $282,909 and 0 sales.
- JOHN SRIVISAL (SVP, Chief Financial Officer) purchased 37,000 shares for an estimated $125,478
- JEAN FRANCOIS TURGEON has made 2 purchases buying 31,150 shares for an estimated $100,026 and 0 sales.
- PETER JOHNSTON purchased 20,000 shares for an estimated $64,200
- JEFFREY N NEUMAN (SVP, General Counsel & Sec.) purchased 10,266 shares for an estimated $50,195
- JEFFREY A. ENGLE (SVP, Commercial and Strategy) purchased 12,600 shares for an estimated $38,682
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$TROX Hedge Fund Activity
We have seen 144 institutional investors add shares of $TROX stock to their portfolio, and 98 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 8,510,649 shares (-36.0%) from their portfolio in Q1 2025, for an estimated $59,914,968
- BLACKROCK, INC. added 4,622,625 shares (+49.7%) to their portfolio in Q2 2025, for an estimated $23,436,708
- THRIVENT FINANCIAL FOR LUTHERANS removed 4,292,238 shares (-98.5%) from their portfolio in Q2 2025, for an estimated $21,761,646
- CAPITAL INTERNATIONAL INVESTORS removed 3,986,039 shares (-65.8%) from their portfolio in Q1 2025, for an estimated $28,061,714
- PRIMECAP MANAGEMENT CO/CA/ added 2,797,002 shares (+192.2%) to their portfolio in Q2 2025, for an estimated $14,180,800
- NUVEEN, LLC removed 1,808,755 shares (-73.7%) from their portfolio in Q2 2025, for an estimated $9,170,387
- CITADEL ADVISORS LLC added 1,591,199 shares (+241.2%) to their portfolio in Q1 2025, for an estimated $11,202,040
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$TROX Analyst Ratings
Wall Street analysts have issued reports on $TROX in the last several months. We have seen 5 firms issue buy ratings on the stock, and 1 firms issue sell ratings.
Here are some recent analyst ratings:
- Goldman Sachs issued a "Buy" rating on 08/07/2025
- UBS issued a "Buy" rating on 07/09/2025
- BMO Capital issued a "Underperform" rating on 06/30/2025
- JP Morgan issued a "Overweight" rating on 05/30/2025
- Barclays issued a "Overweight" rating on 05/28/2025
- Truist Securities issued a "Buy" rating on 04/14/2025
To track analyst ratings and price targets for $TROX, check out Quiver Quantitative's $TROX forecast page.
$TROX Price Targets
Multiple analysts have issued price targets for $TROX recently. We have seen 8 analysts offer price targets for $TROX in the last 6 months, with a median target of $4.75.
Here are some recent targets:
- Duffy Fischer from Goldman Sachs set a target price of $4.5 on 08/07/2025
- Vincent Andrews from Morgan Stanley set a target price of $4.0 on 08/06/2025
- Joshua Spector from UBS set a target price of $3.6 on 08/04/2025
- John Roberts from Mizuho set a target price of $5.0 on 07/15/2025
- John McNulty from BMO Capital set a target price of $3.0 on 06/30/2025
- Jeffrey Zekauskas from JP Morgan set a target price of $7.0 on 05/30/2025
- Michael Leithead from Barclays set a target price of $8.0 on 05/28/2025
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.